 | Up a level |
Kontopoulou, Konstantina; Nakas, Christos Theodore; Ainatzoglou, Alexandra; Ifantidou, Athina; Ntotsi, Paschalina; Katsioulis, Christos; Papazisis, Georgios (2021). Immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in elderly people over 85 years of age in Greece: the GREVAXIMO study. Aging clinical and experimental research, 33(12), pp. 3385-3389. Springer 10.1007/s40520-021-01997-7
Kontopoulou, Konstantina; Ainatzoglou, Alexandra; Nakas, Christos T.; Ifantidou, Athina; Goudi, Georgia; Antoniadou, Eleni; Adamopoulos, Vasilios; Papadopoulos, Nikitas; Papazisis, Georgios (2021). Second dose of the BNT162b2 mRNA vaccine: Value of timely administration but questionable necessity among the seropositive. Vaccine, 39(36), pp. 5078-5081. Elsevier 10.1016/j.vaccine.2021.07.065
Kontopoulou, Konstantina; Ainatzoglou, Alexandra; Ifantidou, Athina; Nakas, Christos T.; Gkounti, Georgia; Adamopoulos, Vasilios; Papadopoulos, Nikitas; Papazisis, Georgios (2021). Immunogenicity after the first dose of the BNT162b2 mRNA Covid-19 vaccine: real-world evidence from Greek healthcare workers. Journal of medical microbiology, 70(8) SGM 10.1099/jmm.0.001387
